SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-056175
Filing Date
2021-11-10
Accepted
2021-11-10 16:05:47
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-8k_20211110.htm   iXBRL 8-K 46254
2 EX-99.1 sdgr-ex991_6.htm EX-99.1 598646
  Complete submission text file 0001564590-21-056175.txt   835876

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20211110.xsd EX-101.SCH 6189
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdgr-20211110_def.xml EX-101.DEF 13791
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20211110_lab.xml EX-101.LAB 24183
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20211110_pre.xml EX-101.PRE 14651
7 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-8k_20211110_htm.xml XML 5274
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 211396516
SIC: 2834 Pharmaceutical Preparations